Association of Time to Kidney Transplantation With Graft Failure Among US Patients With End-Stage Renal Disease Due to Lupus Nephritis

被引:36
|
作者
Plantinga, Laura C. [1 ,2 ]
Patzer, Rachel E. [3 ,4 ]
Drenkard, Cristina [4 ]
Kramer, Michael R. [1 ]
Klein, Mitchel [1 ]
Lim, S. Sam [4 ]
McClellan, William M. [1 ]
Pastan, Stephen O. [3 ,4 ]
机构
[1] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA
[2] Emory Univ, Laney Grad Sch, Atlanta, GA 30322 USA
[3] Emory Healthcare, Emory Transplant Ctr, Atlanta, GA USA
[4] Emory Univ, Sch Med, Atlanta, GA 30322 USA
关键词
HEALTH DISPARITIES; OUTCOMES; RECIPIENTS; MORTALITY; DIALYSIS; ACCESS; GUIDELINES;
D O I
10.1002/acr.22482
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectiveProviders recommend waiting to transplant patients with end-stage renal disease (ESRD) secondary to lupus nephritis (LN), to allow for quiescence of systemic lupus erythematosus (SLE)-related immune activity. However, these recommendations are not standardized, and we sought to examine whether duration of time to transplant was associated with risk of graft failure in US LN-ESRD patients. MethodsUsing national ESRD surveillance data (United States Renal Data System), we identified 4,743 US patients with LN-ESRD who received a first transplant on or after January 1, 2000 (followup through September 30, 2011). The association of wait time (time from ESRD start to transplant) with graft failure was assessed with Cox proportional hazards models, with splines of the exposure to allow for nonlinearity of the association and with adjustment for potential confounding by demographic, clinical, and transplant factors. ResultsWhite LN-ESRD patients who were transplanted later (versus at <3 months receiving dialysis) were at increased risk of graft failure (3-12 months: adjusted hazard ratio [HR] 1.23, 95% confidence interval [95% CI] 0.93-1.63; 12-24 months: adjusted HR 1.37, 95% CI 0.92-2.06; 24-36 months: adjusted HR 1.34, 95% CI 0.92-1.97; and >36 months: adjusted HR 1.98, 95% CI 1.31-2.99). However, no such association was seen among African American recipients (3-12 months: adjusted HR 1.07, 95% CI 0.79-1.45; 12-24 months: adjusted HR 1.01, 95% CI 0.64-1.60; 24-36 months: adjusted HR 0.78, 95% CI 0.51-1.18; and >36 months: adjusted HR 0.74, 95% CI 0.48-1.13). ConclusionWhile future studies are needed to examine the potential confounding effect of clinically recognized SLE activity on the observed associations, these results suggest that longer wait times to transplant may be associated with equivalent or worse, not better, graft outcomes among LN-ESRD patients.
引用
收藏
页码:571 / 581
页数:11
相关论文
共 50 条
  • [1] Access to renal transplantation among patients with end-stage renal disease due to lupus nephritis
    Ward, MM
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (05) : 915 - 922
  • [2] Outcomes of renal transplantation among patients with end-stage renal disease caused by lupus nephritis
    Ward, MM
    KIDNEY INTERNATIONAL, 2000, 57 (05) : 2136 - 2143
  • [3] End-Stage Renal Disease Due to Lupus Nephritis Among Children in the US, 1995-2006
    Hiraki, Linda T.
    Lu, Bing
    Alexander, Steven R.
    Shaykevich, Tamara
    Alarcon, Graciela S.
    Solomon, Daniel H.
    Winkelmayer, Wolfgang C.
    Costenbader, Karen H.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (07): : 1988 - 1997
  • [4] Referral and evaluation for kidney transplantation among patients with lupus nephritis-related end-stage kidney disease
    McPherson, Laura
    Plantinga, Laura C.
    Howards, Penelope P.
    Kramer, Michael
    Pastan, Stephen O.
    Patzer, Rachel E.
    LUPUS, 2024, 33 (01) : 48 - 57
  • [5] Lupus Nephritis and End-stage Kidney Disease
    Maroz, Natallia
    Segal, Mark S.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2013, 346 (04): : 319 - 323
  • [6] Incidence of end-stage renal disease due to lupus nephritis in the US,1995-2004
    Costenbader, Karen H.
    Solomon, Daniel H.
    Winkelmayer, Wolfgang
    Brookhart, M. Alan
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S873 - S873
  • [7] The evolution of lupus activity among patients with end-stage renal disease secondary to lupus nephritis
    Goo, YS
    Park, HC
    Choi, HY
    Kim, BS
    Park, YB
    Lee, SK
    Kang, SW
    Kim, SI
    Kim, YS
    Park, KI
    Lee, HY
    Han, DS
    Choi, KH
    YONSEI MEDICAL JOURNAL, 2004, 45 (02) : 199 - 206
  • [8] Renal transplantation for end-stage renal disease caused by systemic lupus erythematosus nephritis
    Clark, WF
    Jevnikar, AM
    SEMINARS IN NEPHROLOGY, 1999, 19 (01) : 77 - 85
  • [9] Predictors of End-Stage Renal Disease in Lupus Nephritis
    Tselios, Kostantinos
    Gladman, Dafna
    Su, Jiandong
    Urowitz, Murray
    JOURNAL OF RHEUMATOLOGY, 2019, 46 (07) : 813 - 813
  • [10] Predictors of End-Stage Renal Disease in Lupus Nephritis
    Deeb, Mery
    Tselios, Konstantinos
    Gladman, Dafna D.
    Su, Jiandong
    Urowitz, Murray
    ARTHRITIS & RHEUMATOLOGY, 2018, 70